Home / Phenoxybenzamine / United States
US ATC C04AX02 · updated 2 Nov 2026
Phenoxybenzamine shortage in United States
Is there a Phenoxybenzamine shortage in United States?
Yes. As of 2 Nov 2026, 3 Phenoxybenzamine products are reported short in United States, the first since 1 Dec 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) discontinuation | Advanz Pharma (US) Corp. | 1 Dec 2025 | not given | Not stated |
| US | Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) discontinuation | Advanz Pharma (US) Corp. | 1 Dec 2025 | not given | Not stated |
| US | Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) discontinuation | Advanz Pharma (US) Corp. | 1 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).